cryptating agent 222 has been researched along with fluorodeoxyglucose f18 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexoff, DL; Fowler, JS; Gatley, SJ | 1 |
| Brodack, JW; Moerlein, SM; Siegel, BA; Welch, MJ | 1 |
| Chaly, T; Dahl, JR | 1 |
| Alexoff, DL; Ferrieri, RA; Fowler, JS; Schlyer, DJ; Wolf, AP | 1 |
| Mock, BH; Mulholland, GK; Vavrek, MT | 1 |
| Mock, BH; Vavrek, MT; Winkle, W | 1 |
| Channing, MA; Eckelman, WC; Huang, BX; Ma, Y | 1 |
| Ito, T; Nakao, R; Suzuki, K; Yamaguchi, M | 1 |
| Filannino, MA; Kryza, D; Lemoucheux, L; Tadino, V; Villeret, G | 1 |
| Chen, P; Gan, M; Lao, Y; Su, W; Yang, C; Zou, W | 1 |
10 other study(ies) available for cryptating agent 222 and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Removal of the 2.2.2 cryptand (Kryptofix 2.2.2) from 18FDG by cation exchange.
Topics: Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cation Exchange Resins; Chelating Agents; Deoxyglucose; Fluorodeoxyglucose F18 | 1991 |
Elimination of contaminant Kryptofix 2.2.2 in the routine production of 2-[18F]fluoro-2-deoxy-D-glucose.
Topics: Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Chelating Agents; Deoxy Sugars; Deoxyglucose; Drug Contamination; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Radiochemistry | 1989 |
Thin layer chromatographic detection of kryptofix 2.2.2 in the routine synthesis of [18F]2-fluoro-2-deoxy-D-glucose.
Topics: Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Chelating Agents; Chromatography, Thin Layer; Deoxy Sugars; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans | 1989 |
Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector.
Topics: Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chelating Agents; Chromatography, Gas; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Models, Chemical | 1993 |
Back-to-back "one-pot" [18F]FDG syntheses in a single Siemens-CTI chemistry process control unit.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Chelating Agents; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Isotope Labeling; Mice; Quaternary Ammonium Compounds; Radiochemistry | 1996 |
A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Chelating Agents; Chromatography, Thin Layer; Colorimetry; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Indicators and Reagents; Reagent Strips | 1997 |
Quantification of Kryptofix 2.2.2 in 2-[(18)F]FDG and other radiopharmaceuticals by LC/MS/MS.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Chelating Agents; Chromatography, High Pressure Liquid; Fluorodeoxyglucose F18; Radiopharmaceuticals; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2002 |
Simultaneous analysis of FDG, ClDG and Kryptofix 2.2.2 in [18F]FDG preparation by high-performance liquid chromatography with UV detection.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Deoxyglucose; Drug Stability; Fluorodeoxyglucose F18; Pharmaceutical Preparations; Quality Control; Radiopharmaceuticals; Spectrophotometry, Ultraviolet; Stereoisomerism | 2008 |
Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer.
Topics: Alkylation; Bridged Bicyclo Compounds, Heterocyclic; Choline; Equipment Design; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Methylation; Radiochemistry; Radiopharmaceuticals | 2008 |
Quantification of Kryptofix 2.2.2 in [18F]fluorine-labelled radiopharmaceuticals by rapid-resolution liquid chromatography.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2012 |